Alkermes plc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Alkermes plc. (ALKS) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$78.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-28
- Alkermes plc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $41.19M, a 28.73% decline year-over-year.
- Alkermes plc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$119.47M.
- Alkermes plc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $73.03M, a 191.99% increase year-over-year.
- Alkermes plc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$28.25M.
- Alkermes plc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $100.89M.
- Alkermes plc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$57.97M, a 351.93% decline from fiscal 2023.
- Alkermes plc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $23.01M, a 48.12% increase from fiscal 2022.
- Alkermes plc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $15.53M, a 34.91% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $41.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$78.29M 10-Q · filed 2026-07-28 | -$5.26M derived: sum of 3 quarters · filed 2026-07-28 | -$33.50M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2026-03-31 | -$119.47M 10-Q · filed 2026-05-05 | -$46.44M derived: sum of 2 quarters · filed 2026-05-05 | -$74.69M derived: sum of 3 quarters · filed 2026-05-05 | -$16.90M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-12-31 | $73.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $44.78M derived: sum of 2 quarters · filed 2026-02-25 | $102.57M derived: sum of 3 quarters · filed 2026-07-28 | $100.89M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$28.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $29.55M derived: sum of 2 quarters · filed 2026-07-28 | $27.86M 10-Q · filed 2025-10-28 | $52.88M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-06-30 | $57.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $56.11M 10-Q · filed 2026-07-28 | $81.12M derived: sum of 3 quarters · filed 2026-07-28 | $72.00K derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-03-31 | -$1.68M 10-Q · filed 2026-05-05 | $23.33M derived: sum of 2 quarters · filed 2026-05-05 | -$57.72M derived: sum of 3 quarters · filed 2026-05-05 | -$21.20M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $25.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$56.04M derived: sum of 2 quarters · filed 2026-02-25 | -$19.52M derived: sum of 3 quarters · filed 2026-02-25 | -$57.97M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$81.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$44.53M derived: sum of 2 quarters · filed 2025-10-28 | -$82.98M 10-Q · filed 2025-10-28 | -$80.93M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $36.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$1.93M 10-Q · filed 2025-07-29 | $121.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.08M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | -$38.45M 10-Q · filed 2025-05-01 | -$36.40M derived: sum of 2 quarters · filed 2026-02-25 | -$35.43M derived: sum of 3 quarters · filed 2026-02-25 | $14.71M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.01M derived: sum of 2 quarters · filed 2026-02-25 | $53.16M derived: sum of 3 quarters · filed 2026-02-25 | $23.01M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $963.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $51.11M derived: sum of 2 quarters · filed 2024-10-24 | $20.96M 10-Q · filed 2024-10-24 | $30.11M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $50.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $20.00M 10-Q · filed 2024-07-24 | $29.14M derived: sum of 3 quarters · filed 2025-02-12 | $56.33M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$30.15M 10-Q · filed 2024-05-01 | -$21.01M derived: sum of 2 quarters · filed 2025-02-12 | $6.18M derived: sum of 3 quarters · filed 2025-02-12 | $18.79M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $9.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $36.34M derived: sum of 2 quarters · filed 2025-02-12 | $48.95M derived: sum of 3 quarters · filed 2025-02-12 | $15.53M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $27.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $39.80M derived: sum of 2 quarters · filed 2023-10-25 | $6.39M 10-Q · filed 2023-10-25 | $4.81M 10-Q · filed 2022-11-02 | $2.35M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $12.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | -$20.80M 10-Q · filed 2023-07-26 | -$29.05M 10-Q · filed 2022-07-27 | -$24.83M derived: sum of 3 quarters · filed 2024-02-21 | $43.34M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | -$33.41M 10-Q · filed 2023-04-26 | -$5.46M 10-Q · filed 2022-04-27 | -$37.45M derived: sum of 2 quarters · filed 2024-02-21 | $30.73M derived: sum of 3 quarters · filed 2024-02-21 | $50.05M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | -$4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $64.14M derived: sum of 2 quarters · filed 2024-02-21 | $83.46M derived: sum of 3 quarters · filed 2024-02-21 | $11.51M 10-K · filed 2024-02-21 | $29.85M 10-K · filed 2022-02-16 | |||
| 2021-09-30 | $68.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $87.50M derived: sum of 2 quarters · filed 2022-11-02 | $15.55M 10-Q · filed 2022-11-02 | $7.39M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | $19.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$52.63M 10-Q · filed 2022-07-27 | -$60.78M derived: sum of 3 quarters · filed 2023-02-16 | $1.26M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | -$71.95M 10-Q · filed 2022-04-27 | -$80.10M derived: sum of 2 quarters · filed 2023-02-16 | -$18.06M derived: sum of 3 quarters · filed 2023-02-16 | -$35.07M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | -$8.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $53.88M derived: sum of 2 quarters · filed 2023-02-16 | $36.88M derived: sum of 3 quarters · filed 2023-02-16 | -$14.38M 10-K · filed 2023-02-16 | $50.60M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $62.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $45.03M derived: sum of 2 quarters · filed 2021-10-27 | -$6.22M 10-Q · filed 2021-10-27 | $8.08M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | -$17.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$68.26M 10-Q · filed 2021-07-28 | -$53.95M derived: sum of 3 quarters · filed 2022-02-16 | -$23.50M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | -$51.25M 10-Q · filed 2021-04-28 | -$36.95M derived: sum of 2 quarters · filed 2022-02-16 | -$6.49M derived: sum of 3 quarters · filed 2022-02-16 | -$519.00K derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | $14.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $44.77M derived: sum of 2 quarters · filed 2022-02-16 | $50.73M derived: sum of 3 quarters · filed 2022-02-16 | $34.85M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $30.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $36.43M derived: sum of 2 quarters · filed 2020-10-29 | $20.54M 10-Q · filed 2020-10-29 | $54.38M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $5.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$9.92M 10-Q · filed 2020-07-29 | $23.92M derived: sum of 3 quarters · filed 2021-02-11 | $39.45M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | -$15.89M 10-Q · filed 2020-04-29 | $17.95M derived: sum of 2 quarters · filed 2021-02-11 | $33.48M derived: sum of 3 quarters · filed 2021-02-11 | $44.97M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $33.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $49.36M derived: sum of 2 quarters · filed 2021-02-11 | $60.86M derived: sum of 3 quarters · filed 2021-02-11 | $46.74M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $15.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $27.02M derived: sum of 2 quarters · filed 2019-10-23 | $12.90M 10-Q · filed 2019-10-23 | $42.13M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $11.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$2.62M 10-Q · filed 2019-07-25 | $26.60M derived: sum of 3 quarters · filed 2020-02-13 | $56.63M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | -$14.12M 10-Q · filed 2019-04-25 | $15.11M derived: sum of 2 quarters · filed 2020-02-13 | $45.13M derived: sum of 3 quarters · filed 2020-02-13 | $60.27M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $29.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $59.26M derived: sum of 2 quarters · filed 2020-02-13 | $74.39M derived: sum of 3 quarters · filed 2020-02-13 | $72.66M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $30.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $45.16M derived: sum of 2 quarters · filed 2018-10-23 | $43.43M 10-Q · filed 2018-10-23 | $62.47M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-06-30 | $15.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $13.40M 10-Q · filed 2018-07-26 | $32.44M derived: sum of 3 quarters · filed 2019-02-15 | $46.57M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-03-31 | -$1.73M 10-Q · filed 2018-04-26 | $17.31M derived: sum of 2 quarters · filed 2019-02-15 | $31.44M derived: sum of 3 quarters · filed 2019-02-15 | $44.82M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2016-12-31 | $19.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $33.17M derived: sum of 2 quarters · filed 2019-02-15 | $46.55M derived: sum of 3 quarters · filed 2019-02-15 | $45.87M 10-K · filed 2019-02-15 | ||||
| 2016-09-30 | $14.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $27.51M derived: sum of 2 quarters · filed 2017-10-26 | $26.83M 10-Q · filed 2017-10-26 | $56.70M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $13.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $12.70M 10-Q · filed 2017-07-27 | $42.57M derived: sum of 3 quarters · filed 2018-02-16 | $67.72M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | -$680.00K 10-Q · filed 2017-04-27 | $29.18M derived: sum of 2 quarters · filed 2018-02-16 | $54.34M derived: sum of 3 quarters · filed 2018-02-16 | $85.78M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $29.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $55.02M derived: sum of 2 quarters · filed 2018-02-16 | $86.46M derived: sum of 3 quarters · filed 2018-02-16 | $76.16M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | $25.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $56.59M derived: sum of 2 quarters · filed 2016-11-02 | $46.29M 10-Q · filed 2016-11-02 | $78.08M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $31.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $21.14M 10-Q · filed 2016-07-28 | $52.93M derived: sum of 3 quarters · filed 2017-02-17 | $74.34M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | -$10.30M 10-Q · filed 2016-04-28 | $21.49M derived: sum of 2 quarters · filed 2017-02-17 | $42.90M derived: sum of 3 quarters · filed 2017-02-17 | $49.68M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $31.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $53.20M derived: sum of 2 quarters · filed 2017-02-17 | $59.98M derived: sum of 3 quarters · filed 2017-02-17 | $56.90M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $21.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $28.19M derived: sum of 2 quarters · filed 2015-10-29 | $25.10M 10-Q · filed 2015-10-29 | $48.96M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $3.69M 10-Q · filed 2015-07-30 | $27.55M derived: sum of 3 quarters · filed 2016-02-25 | $29.49M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | -$3.08M 10-Q · filed 2015-04-30 | $20.77M derived: sum of 2 quarters · filed 2016-02-25 | $22.71M derived: sum of 3 quarters · filed 2016-02-25 | $13.04M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $23.85M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $25.79M derived: sum of 2 quarters · filed 2016-02-25 | $16.13M 10-K · filed 2016-02-25 | $42.72M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-09-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31 | -$7.73M 10-Q · filed 2013-10-31 | $18.87M 10-Q · filed 2014-10-29 | $29.10M derived: sum of 4 quarters · filed 2014-04-30 | ||||
| 2013-06-30 | -$9.67M 10-Q · filed 2013-07-25 | $16.93M 10-Q · filed 2014-07-31 | $27.16M derived: sum of 3 quarters · filed 2014-04-30 | $28.57M derived: sum of 4 quarters · filed 2014-04-30 | ||||
| 2013-03-31 | $26.60M 10-Q · filed 2014-04-30 | $36.83M derived: sum of 2 quarters · filed 2014-04-30 | $38.23M derived: sum of 3 quarters · filed 2014-04-30 | $19.41M 10-K · filed 2015-02-24 | ||||
| 2012-12-31 | $10.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $11.64M derived: sum of 2 quarters · filed 2013-10-31 | -$7.19M 10-Q · filed 2013-01-31 | -$15.61M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-09-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31 | -$17.42M 10-Q · filed 2013-10-31 | -$25.84M derived: sum of 3 quarters · filed 2014-02-27 | -$25.79M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | -$18.83M 10-Q · filed 2013-07-25 | -$18.93M 10-Q · filed 2012-07-26 | -$27.25M derived: sum of 2 quarters · filed 2014-02-27 | -$27.20M derived: sum of 3 quarters · filed 2014-02-27 | -$40.00K derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-03-31 | -$8.42M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | -$8.37M derived: sum of 2 quarters · filed 2014-02-27 | $18.79M derived: sum of 3 quarters · filed 2014-02-27 | $15.55M 10-KT · filed 2014-02-27 | $11.22M 10-K · filed 2012-05-18 | |||
| 2011-12-31 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $27.20M derived: sum of 2 quarters · filed 2013-01-31 | $23.97M 10-Q · filed 2013-01-31 | $20.84M 10-Q · filed 2012-02-02 | $35.85M derived: sum of 4 quarters · filed 2013-05-23 | |||
| 2011-09-30 | $27.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-01 | $23.92M 10-Q · filed 2012-11-01 | $20.79M 10-Q · filed 2011-11-03 | $35.80M derived: sum of 3 quarters · filed 2013-05-23 | $38.59M derived: sum of 4 quarters · filed 2013-05-23 | |||
| 2011-06-30 | -$3.23M 10-Q · filed 2012-07-26 | $8.65M derived: sum of 2 quarters · filed 2013-05-23 | $11.43M derived: sum of 3 quarters · filed 2013-05-23 | |||||
| 2011-03-31 | $11.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-23 | $14.66M derived: sum of 2 quarters · filed 2013-05-23 | $6.95M 10-K · filed 2013-05-23 | |||||
| 2010-12-31 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | -$4.93M 10-Q · filed 2012-02-02 | ||||||
| 2010-09-30 | -$7.71M 10-Q · filed 2011-11-03 | |||||||
| 2010-03-31 | -$2.06M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |